The Only Industry-Dedicated Summit for Advancing Myeloid Cell Therapies in Oncology, Inflammation and Beyond…

Uniting leading experts from pharma, biotech, and academia, the 7th Myeloid-Directed Therapies Summit is the definitive event for anyone developing macrophage- and neutrophil-targeted therapies. As the field pushes beyond T-cells, this forum dives into myeloid reprogramming, cell state heterogeneity, and translational challenges to unlock next-generation immune modulation.

With breakthrough insights from Eli Lilly, AbbVie, Pfizer, AstraZeneca, and Faron Pharmaceuticals, and cutting-edge academic labs, this is your opportunity to explore clinical case studies, dissect failed monotherapy lessons, and gain clarity on patient stratification, trial design, and combination strategies.

Learn more: https://ter.li/by8e82